🗞️ News
Our report from @europeanrespsoc.bsky.social #ERS2026 covers phase 3 data on tozorakimab, new data on ralinepag, high-dose influenza vaccine, astegolimab, and lunsekimig.
Written by Priya Venkatesan
Check out the full report: www.thelancet.com/journals/lan...
